| 000 | 00882 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513130802.0 | ||
| 264 | 0 | _c19971126 | |
| 008 | 199711s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/S0140-6736(05)62495-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aForbes, A | |
| 245 | 0 | 0 |
_aMesalazine preparations. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cNov 1997 |
||
| 300 |
_a1329 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aMesalamine _xtherapeutic use |
| 700 | 1 | _aChadwick, C | |
| 773 | 0 |
_tLancet (London, England) _gvol. 350 _gno. 9087 _gp. 1329 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(05)62495-6 _zAvailable from publisher's website |
| 999 |
_c9327689 _d9327689 |
||